Skip to content

1Day Sooner

    • Volunteer
    • What is a Challenge Study?
    • Meet 1Day Volunteers
    • Participant Council
    • Informed Consent Guide
    • Recruiting Challenge Studies
    • About 1Day Sooner
    • 1Day Sooner Team
    • Finances & Transparency
    • Careers
  • Events
  • CPO Investigator Hub
    • Study Support for Investigators
    • Frequently Asked Questions
    • Public & Patient Involvement Alignment
    • Case Studies
      • Malawi Liverpool Wellcome Research Programme
      • Hepatitis C Human Challenge Trial
    • 1Day Sooner Blog
    • 1Day Sooner in the News
    • Newsletters
    • Press Releases
    • Research & Publications
    • Briefs & Reports
    • Challenge Study Compendium
    • Target Product Profile Design
    • Volunteer Support
    • Clinical Trial Abundance
    • Pandemic Preparedness
    • Pandemic Insurance Fund
    • Challenge Model Development
      • Group A Strep
      • Tuberculosis
      • Hepatitis C Human Challenge Studies
  • Contact Us
  • Merch
  • 1Day Africa
  • 1Day UK
  • Find 1Day Sooner on Facebook
  • Find 1Day Sooner on Instagram
  • Find 1Day Sooner on Twitter
  • Find 1Day Sooner on YouTube
Donate
Donate
  • Pandemic Preparedness

    August 26, 2026

    Secure Africa’s Health Infrastructure Through Sustained Investment in AMA

    The African Medicines Agency (AMA) has been widely celebrated as a turning point for African regulatory sovereignty. Headquartered in Kigali,…

  • Volunteers

    July 27, 2026

    Meet Marcus Dahl: Supporting Research He Believes In

    Marcus Dahl, an Australian living and working in the UK, decided to join his first clinical trial in about five…

  • Team

    July 9, 2026

    Meet the Team: Zacharia Kafuko, 1Day Africa Director

    This post is part of a series spotlighting the members of 1Day Sooner’s team. They explain how we work toward…

  • Volunteers

    June 11, 2026

    Meet Elizabeth Rouha: Making Research Participation Less Intimidating

    Elizabeth Rouha learned about the clinical trial she would later join in an unusual place: “I was at a restaurant…

  • Volunteers

    May 12, 2026

    Meet Roopesh Chavda: A Healthy Participant Turned Advocate

    Roopesh Chavda is an engineer with a background in mathematics, and the kind of person who responds to a crisis…

  • Team

    May 7, 2026

    Meet the Team: Paul Zimmer-Harwood, Research Lead for Clinical Trials

    This post is the first in a series spotlighting the members of 1Day Sooner’s team. They will explain how we…

  • Volunteers

    April 7, 2026

    Meet Angelique Mseteka: A Participant in Malawi’s First CHIM Trial

    Angelique Mseteka is a registered nurse based in Salima, Malawi. When she heard about a clinical trial studying pneumococcal vaccines…

  • Regulatory

    December 8, 2025

    R21 Price Cut Unlocks $1 Billion for Malaria Vaccination in Africa

    By Zacharia Kafuko (Director of 1Day Africa) and Ollie Sayeed, PhD The international vaccine provider Gavi and the UN children’s…

  • Regulatory

    May 28, 2025

    Ripple effects: How U.S. FDA layoffs threaten global health in low- and middle-income countries and weaken US competitiveness

    By Philip Kenol & Enlli Lewis The recent staffing cuts at the U.S. Food and Drug Administration (FDA), which affected…

  • Regulatory

    March 10, 2025

    Building on the success of Operation Warp Speed

    Operation Warp Speed (OWS) was a groundbreaking public-private partnership that accelerated the development of COVID-19 vaccines, setting a model for…

  • Malaria

    March 7, 2025

    Cost-effectiveness of malaria interventions: a systematic review

    Authored by The 1Day Africa research team. This project was a collaboration by Ollie Sayeed, Isla Gibson, Hannah Greene, Iain…

  • Malaria

    December 16, 2024

    Malaria Vaccines: Turning a Scientific Triumph into Millions of Lives Saved

    After decades of research and development, two new malaria vaccines entered routine administration this year. This is a huge win…

  • COVID-19

    December 12, 2024

    Applying Pull Funding & Regulatory Capacity to Advance New Biotechnologies & Prevent Pandemics: Operation Warp Speed 2.0 Conference

    Last week, 1Day Sooner convened more than 80 of the nation’s top health, biosecurity, and research leaders for our third…

  • Malaria

    November 14, 2024

    Why America can’t afford to ignore malaria

    by Ollie Sayeed, Ph.D. In 1749, a young land surveyor named George Washington set out into the wetlands of Virginia,…

  • Malaria

    September 27, 2024

    Speeding up the Gavi submission process

    by Ollie Sayeed, Ph.D. The historic malaria vaccine roll-out that began in earnest earlier this year is directed by Gavi,…

  • Malaria

    September 10, 2024

    Overcoming vaccine misinformation

    By Iain Macleod Briongos, Ph.D. Introduction Misinformation – the spread of incorrect, inaccurate, incomplete, or misleading information – has become…

  • Prev
  • Page 1
  • …
  • Page 3
  • Next

1Day Sooner

  • Contact Us
  • Merch
  • 1Day Africa
  • 1Day UK
  • Find 1Day Sooner on Facebook
  • Find 1Day Sooner on Instagram
  • Find 1Day Sooner on Twitter
  • Find 1Day Sooner on YouTube
Donate
  • Volunteer Hub
    • Volunteer
    • What is a Challenge Study?
    • Meet 1Day Volunteers
    • Participant Council
    • Informed Consent Guide
    • Recruiting Challenge Studies
  • About Us
    • About 1Day Sooner
    • 1Day Sooner Team
    • Finances & Transparency
    • Careers
  • Events
  • CPO Investigator Hub
    • Study Support for Investigators
    • Frequently Asked Questions
    • Public & Patient Involvement Alignment
    • Case Studies
      • Malawi Liverpool Wellcome Research Programme
      • Hepatitis C Human Challenge Trial
  • Media
    • 1Day Sooner Blog
    • 1Day Sooner in the News
    • Newsletters
    • Press Releases
  • Research
    • Research & Publications
    • Briefs & Reports
    • Challenge Study Compendium
    • Target Product Profile Design
  • Advocacy
    • Volunteer Support
    • Clinical Trial Abundance
    • Pandemic Preparedness
    • Pandemic Insurance Fund
    • Challenge Model Development
      • Group A Strep
      • Tuberculosis
      • Hepatitis C Human Challenge Studies
  • Privacy Policy

© 2026 1Day Sooner. All Rights Reserved. Site made in collaboration with CMYK